Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Co-morbidity and Drug Abuse. In Report to the EMCDDA by the Reitox National

In English

Författare

  • Mats Fridell

Summary, in English

The chapter by definition focuses on Swedish research and treatment practice in the area of comorbiditity. Three “ethiological” lines of comorbidity is outlined. it thus seems warranted to look upon patients with a precipitating psychiatric diagnosis and a consequent problem of alcohol and/or substance abuse as one specific model/type (1). A second type representting the drug and substance dependent person who´s psychiatric and psychological problems often remain unattended until a more thorough assessment is made. Here, personality disorders are by far the most common disorder. Model 3, finally, corresponds to a number of alcohol- and substance dependent persons who are not afflicted by any particular chronical psychiatric or psychological problem despite the severity of the alcohol/substance problem. The reason for differentiating specific comorbid patterns are, apart from diagnostic utility, also the need to gauge treatment carefully. The immediate ways of approaching the patient in a treatment encounter as well as for choosing an adequate treatment intervention differ and contain different possible combinations of psychosocial and pharmacological interventions. The national records of the Swedish National Board of Health and Welfare underreport systematically due to the fact the diagnostic procedures is lacking in clinical treatment and diagnoses consequently reported scarcely. The situations within the hospital system, in prisons and other treatment settings are presented, leaving a clear picture of a heavily afflicted group of patients, where their psychiatric ailments are only dealt with in a few clinics. In drug dependent individuals (type 2), personality disorders are be far the most common problem ranging from 60–85% in clinical settings.

Publiceringsår

2004

Språk

Engelska

Sidor

87-128

Publikation/Tidskrift/Serie

2003 to the EMCDDA by the Reitox National Focal Point. Sweden – Drug Situation 2002

Volym

R2004:25

Dokumenttyp

Del av eller Kapitel i bok

Förlag

National Institute of Public Health, Sweden

Ämne

  • Psychology

Status

Published

ISBN/ISSN/Övrigt

  • ISBN: 91-7257-283-3